Exogenous Huntingtin-Exon1 Aggregates Exhibit Distinct Levels of Toxicity to Caenorhabditis elegans
- 23 September 2025
- journal article
- Published by American Chemical Society (ACS) in ACS Chemical Neuroscience
- Vol. 16 (20) , 4037-4049
Abstract
Many neurodegenerative diseases, including Alzheimer's (AD), Parkinson's (PD), and Huntington's disease (HD), are associated with proteinaceous deposits in the brain comprising amyloid. The aggregation process leading to these deposits proceeds through a variety of intermediates, i.e., oligomers and fibrils. The heterogeneity of aggregates produced complicates the assignment of specific toxic functions to distinct aggregate species. Here, a simple centrifugation strategy was employed to produce well-characterized and relatively homogeneous populations of huntingtin (htt) aggregates in vitro. After characterization of the resulting aggregate populations, C. elegans were exogenously exposed to these different aggregates species to assess their impact on worm viability. Htt oligomers were identified as the most acutely toxic aggregate form. Nonaggregated htt and fibrils did not significantly reduce C. elegans viability. A variety of methods to manipulate htt oligomers were then tested to demonstrate the ability to modify oligomer toxicity in this model system. Chemically cross-linking htt oligomers reduced their toxicity, suggesting that structural flexibility is important in oligomer toxicity. Stabilizing oligomers with truncated peptides based on the first 17 N-terminal amino acids (Nt17) impacted toxicity when specific acetylation-mimicking point mutations were introduced. Nt17-derived peptides without any mutations did not alter toxicity; however, the addition of acetylation-mimicking mutations toward the C-terminus of the peptide reduces toxicity. Finally, two small molecules that modify htt aggregation, EGCG and riluzole, were tested for their impact on oligomer toxicity. In general, this approach provides a simple method to investigate and manipulate the toxicity of aggregate subpopulation in a quasi-controlled manner.Keywords
Funding Information
- Division of Chemistry (1559654)
- Arnold and Mabel Beckman Foundation
- West Virginia University
This publication has 59 references indexed in Scilit:
- Charge within Nt17 peptides modulates huntingtin aggregation and initial lipid binding eventsBiophysical Chemistry, 2023
- In Situ Architecture and Cellular Interactions of PolyQ InclusionsCell, 2017
- Huntingtin Inclusions Trigger Cellular Quiescence, Deactivate Apoptosis, and Lead to Delayed NecrosisCell Reports, 2017
- Mutant Exon1 Huntingtin Aggregation is Regulated by T3 Phosphorylation‐Induced Structural Changes and Crosstalk between T3 Phosphorylation and Acetylation at K6Angewandte Chemie International Edition, 2017
- Acetylation within the First 17 Residues of Huntingtin Exon 1 Alters Aggregation and Lipid BindingBiophysical Journal, 2016
- Protein aggregates in Huntington's diseaseExperimental Neurology, 2012
- Sub‐Diffraction Imaging of Huntingtin Protein Aggregates by Fluorescence Blink‐Microscopy and Atomic Force MicroscopyChemphyschem, 2011
- Acetylation Targets Mutant Huntingtin to Autophagosomes for DegradationCell, 2009
- In situ AFM studies of astrocyte-secreted apolipoprotein E- and J-containing lipoproteinsJournal of Colloid and Interface Science, 2004
- A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomesCell, 1993